Search Results - Lester, Jenny
- Showing 1 - 20 results of 90
- Go to Next Page
-
1
-
2
21 Code of Federal Regulations Part 11–Compliant Digital Signature Solution for Cancer Clinical Trials: A Single-Institution Feasibility Study by Miller, Therica M., Lester, Jenny, Kwan, Lorna, Tandel, Megha D., Karlan, Beth Y., Rimel, BJ
Published 2020Text -
3
Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma by Novak, Marián, Lester, Jenny, Karst, Alison M., Parkash, Vinita, Hirsch, Michelle S., Crum, Christopher P., Karlan, Beth Y., Drapkin, Ronny
Published 2015Text -
4
-
5
ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma by Cheon, Dong-Joo, Li, Andrew J., Beach, Jessica A., Walts, Ann E., Tran, Hang, Lester, Jenny, Karlan, Beth Y., Orsulic, Sandra
Published 2015Text -
6
Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens by Prendergast, Emily N., de Souza Fonseca, Marcos Abraão, Dezem, Felipe Segato, Lester, Jenny, Karlan, Beth Y., Noushmehr, Houtan, Lin, Xianzhi, Lawrenson, Kate
Published 2018Text -
7
Focal Serous Tubal Intra-Epithelial Carcinoma Lesions Are Associated With Global Changes in the Fallopian Tube Epithelia and Stroma by Wu, Jingni, Raz, Yael, Recouvreux, Maria Sol, Diniz, Márcio Augusto, Lester, Jenny, Karlan, Beth Y., Walts, Ann E., Gertych, Arkadiusz, Orsulic, Sandra
Published 2022Text -
8
Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas by Cheon, Dong‐Joo, Walts, Ann E, Beach, Jessica A, Lester, Jenny, Bomalaski, John S, Walsh, Christine S, Ruprecht Wiedemeyer, W, Karlan, Beth Y, Orsulic, Sandra
Published 2014Text -
9
Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary? by Hu, Ye, Taylor-Harding, Barbie, Raz, Yael, Haro, Marcela, Recouvreux, Maria Sol, Taylan, Enes, Lester, Jenny, Millstein, Joshua, Walts, Ann E., Karlan, Beth Y., Orsulic, Sandra
Published 2020Text -
10
A collagen-remodeling gene signature regulated by TGFβ signaling is associated with metastasis and poor survival in serous ovarian cancer by Cheon, Dong-Joo, Tong, Yunguang, Sim, Myung-Shin, Dering, Judy, Berel, Dror, Cui, Xiaojiang, Lester, Jenny, Beach, Jessica A., Tighiouart, Mourad, Walts, Ann E., Karlan, Beth Y., Orsulic, Sandra
Published 2013Text -
11
Early loss of Histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer. by Hooda, Jagmohan, Novak, Marián, Salomon, Matthew P., Matsuba, Chikako, Ramos, Romela I., MacDuffie, Emily, Song, Melissa, Hirsch, Michelle S., Lester, Jenny, Parkash, Vinita, Karlan, Beth Y., Oren, Moshe, Hoon, Dave S., Drapkin, Ronny
Published 2018Text -
12
STAT3/PIAS3 levels serve as “early signature” genes in the development of high-grade serous carcinoma from the fallopian tube by Saini, Uksha, Suarez, Adrian A., Naidu, Shan, Wallbillich, John J., Bixel, Kristin, Wanner, Ross A., Bice, Jason, Kladney, Raleigh D., Lester, Jenny, Karlan, Beth Y., Goodfellow, Paul J., Cohn, David E., Selvendiran, Karuppaiyah
Published 2018Text -
13
Characteristics of 10-year survivors of high-grade serous ovarian carcinoma by Dao, Fanny, Schlappe, Brooke A, Tseng, Jill, Lester, Jenny, Nick, Alpa M., Lutgendorf, Susan K., McMeekin, Scott, Coleman, Robert L., Moore5, Kathleen N., Karlan, Beth Y., Sood, Anil K., Levine, Douglas A
Published 2016Text -
14
Quality of Life among Long-Term Survivors of Advanced Stage Ovarian Cancer: A Cross-Sectional Approach by Lutgendorf, Susan K., Shinn, Eileen, Carter, Jeanne, Leighton, Susan, Baggerly, Keith, Guindani, Michele, Fellman, Bryan, Matzo, Marianne, Slavich, George M., Goodman, Marc T., Tew, William, Lester, Jenny, Moore, Kathleen M., Karlan, Beth Y., Levine, Douglas A., Sood, Anil K.
Published 2017Text -
15
Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial by Pace, Lydia E., Lee, Yeonsoo S., Tung, Nadine, Hamilton, Jada G., Gabriel, Camila, Raja, Sahitya C., Jenkins, Colby, Braswell, Anthony, Domchek, Susan M., Symecko, Heather, Spielman, Kelsey, Karlan, Beth Y., Lester, Jenny, Kamara, Daniella, Levin, Jeffrey, Morgan, Kelly, Offit, Kenneth, Garber, Judy, Keating, Nancy L.
Published 2020Text -
16
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers by Lin, De-Chen, Xu, Liang, Ding, Ling-Wen, Sharma, Arjun, Liu, Li-Zhen, Yang, Henry, Tan, Patrick, Vadgama, Jay, Karlan, Beth Y., Lester, Jenny, Urban, Nicole, Schummer, Michèl, Doan, Ngan, Said, Jonathan W., Sun, Hongmao, Walsh, Martin, Thomas, Craig J., Patel, Paresma, Yin, Dong, Chan, Daniel, Koeffler, H. Phillip
Published 2013Text -
17
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study by Pace, Lydia E., Tung, Nadine, Lee, Yeonsoo S., Hamilton, Jada G., Gabriel, Camila, Revette, Anna, Raja, Sahitya, Jenkins, Colby, Braswell, Anthony, Morgan, Kelly, Levin, Jeffrey, Block, Jeremy, Domchek, Susan M., Nathanson, Katherine, Symecko, Heather, Spielman, Kelsey, Karlan, Beth, Kamara, Daniella, Lester, Jenny, Offit, Kenneth, Garber, Judy E., Keating, Nancy L.
Published 2021Text -
18
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics by Sims, Jessica D., Taguiam, Jan Michael, Alonso-Valenteen, Felix, Markman, Janet, Agadjanian, Hasmik, Chu, David, Lubow, Jay, Abrol, Ravinder, Srinivas, Dustin, Jain, Anjali, Han, Bingchen, Qu, Ying, Mirzadehgan, Parisa, Hwang, Jae-Youn, Rentsendorj, Altan, Chung, Alice, Lester, Jenny, Karlan, Beth Y., Gray, Harry B., Gross, Zeev, Giuliano, Armando, Cui, Xiaojiang, Medina-Kauwe, Lali K.
Published 2017Text -
19
DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers by Gull, Nicole, Jones, Michelle R., Peng, Pei-Chen, Coetzee, Simon G., Silva, Tiago C., Plummer, Jasmine T., Reyes, Alberto Luiz P., Davis, Brian D., Chen, Stephanie S., Lawrenson, Kate, Lester, Jenny, Walsh, Christine, Rimel, Bobbie J., Li, Andrew J., Cass, Ilana, Berg, Yonatan, Govindavari, John-Paul B., Rutgers, Joanna K. L., Berman, Benjamin P., Karlan, Beth Y., Gayther, Simon A.
Published 2022Text -
20
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis by Wohlmuth, Christoph, Djedovic, Vladimir, Kjaer, Susanne K., Jensen, Allan, Glasspool, Rosalind, Roxburgh, Patricia, DeFazio, Anna, Johnatty, Sharon E., Webb, Penelope M., Modugno, Francesmary, Lambrechts, Diether, Schildkraut, Joellen M., Berchuck, Andrew, Thomsen, Liv Cecilie Vestrheim, Bjorge, Line, Høgdall, Estrid, Høgdall, Claus K., Goode, Ellen L., Winham, Stacey J., Matsuo, Keitaro, Karlan, Beth Y., Lester, Jenny, Goodman, Marc T., Thompson, Pamela J., Pejovic, Tanja, Riggan, Marjorie J., Lajkosz, Katherine, Tone, Alicia, May, Taymaa
Published 2022Text